MétaCan
Menu
← Back to cohort
Record W4406224633 · doi:10.1002/alz.087439

Performance of a new instrument designed to assess medication use in cognitive impairment and dementia: A cross‐sectional analysis

2024· article· en· W4406224633 on OpenAlexaff
Rishabh Sharma, Linda Lee, Feng Chang, Tejal Patel

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldMedicine
TopicPharmaceutical Practices and Patient Outcomes
Canadian institutionsResearch Institute for AgingUniversity of Waterloo
Fundersnot available
KeywordsDementiaCross-sectional studyCognitive impairmentMedicineCognitionGerontologyPsychologyPsychiatryDiseaseInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background The Medication Review in Cognitive Impairment and Dementia (MedRevCiD) checklist is a new tool designed to assist health care professionals in optimizing medication use in individuals with Mild Cognitive Impairment (MCI) or dementia. It consists of 6 domains, each of which addresses a specific medication use issue such as medication management and adherence. The primary objective of this study was to compare the mean number of drug‐related problems (DRPs) identified with MedRevCiD Checklist to the Medication Appropriateness Index (MAI) in older adults attending a primary care‐based memory clinic. Methods A cross‐sectional analysis was conducted at a Multi‐speciality Interprofessional Team‐based (MINT) memory clinic. A medication review was conducted by applying the MAI initially, followed by application of the MedRevCiD checklist to assess medication use and to identify DRPs for participants enrolled in the study. The Wilcoxon signed‐rank test was used to determine if a significant difference exists in the average number of DRPs per person as identified through MedRevCiD compared to MAI. Results A total of 44 participants with a mean age of 80.2 ± 6.2 years enrolled in the study. Of the participants, 45.5% (20/44) were female, 36.4% (16/44) had mild cognitive impairment, 20.5% (9/44) had mixed dementia and 11.4% (5/44) had vascular dementia. Participants had an average of 6.7 ± 3.4 comorbidities, most commonly hypertension (63.6%, 28/44), hyperlipidemia (31.8%, 14/44), chronic kidney disease (27.2%, 12/44) and obstructive sleep apnea (25%, 11/44). Participants were taking a median of 7.5 medications (interquartile range 6) per person. A total of 134 DRPs were identified with the use of the MedRevCiD as compared with 81 with the use of the MAI (mean 3.05 ± 4.0 with MedRevCiD vs 1.84 ± 2.9 with MAI; p<0.001). Over 50% of the DRPs identified with the MedRevCiD fell within Domain 6 which focuses on optimizing medication use, while the majority of the DRPs identified from the MAI were focused on drug/disease interactions. Conclusion Findings provide insight into the frequency of DRPs among older adults with MCI or dementia. The MedRevCiD checklist proved to be a valuable tool with heightened ability in detecting DRPs in this population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.004
Threshold uncertainty score0.024

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.006
Meta-epidemiology (narrow)0.0000.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.167
GPT teacher head0.416
Teacher spread0.249 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicPharmaceutical Practices and Patient Outcomes→French-language works237,207→